1. Home
  2. LYRA vs IFBD Comparison

LYRA vs IFBD Comparison

Compare LYRA & IFBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyra Therapeutics Inc.

LYRA

Lyra Therapeutics Inc.

HOLD

Current Price

$3.97

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Logo Infobird Co. Ltd

IFBD

Infobird Co. Ltd

HOLD

Current Price

$0.97

Market Cap

8.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LYRA
IFBD
Founded
2005
2001
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
8.4M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
LYRA
IFBD
Price
$3.97
$0.97
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
94.1K
20.8K
Earning Date
11-12-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$600,000.00
$4,861,442.00
Revenue This Year
N/A
N/A
Revenue Next Year
$93.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1520.48
52 Week Low
$2.84
$0.88
52 Week High
$37.50
$2.74

Technical Indicators

Market Signals
Indicator
LYRA
IFBD
Relative Strength Index (RSI) 43.81 44.31
Support Level $3.93 $0.90
Resistance Level $4.59 $1.18
Average True Range (ATR) 0.43 0.08
MACD 0.20 0.00
Stochastic Oscillator 64.57 27.84

Price Performance

Historical Comparison
LYRA
IFBD

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About IFBD Infobird Co. Ltd

Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.

Share on Social Networks: